Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Glioblastoma 21Brain Neoplasms 9Neoplasms 7Glioma 6Astrocytoma 4Recurrence 3Solid Tumor 1Sarcoma 1Pancreatic Neoplasms 1Neoplasm Recurrence, Local 1Neoplasm Metastasis 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Leukemia-Lymphoma, Adult T-Cell 1Kidney Neoplasms 1Hereditary Sensory and Autonomic Neuropathies 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Camurati-Engelmann Syndrome 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Ibandronic Acid 8Zoledronic Acid 5Irinotecan 3Temozolomide 2Radiation 2Doxorubicin 2Denosumab 2Cyclophosphamide 2Cryotherapy 2Cryosurgery 2selinexor 1saracatinib 1robatumumab 1ridaforolimus 1radium Ra 223 dichloride 1pegfilgrastim 1palbociclib 1liposomal doxorubicin 1cc-486 1anlotinib 1Vincristine 1Topotecan 1Taxes 1Radiotherapy 1Quality of Life 1Pregabalin 1Patient Reported Outcome Measures 1Paclitaxel 1Observation 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Bone Neoplasms × Lomustine × Clear all
NCT03678883 2026-04-03

9-ING-41 in Patients With Advanced Cancers

Actuate Therapeutics Inc.

Phase 2 Active not recruiting
350 enrolled
BreastCNSGastrointestinalGenitourinaryLymphoidOther hematologic neoplasmSarcomaThoracic

Bone Neoplasms, Breast Neoplasms, Glioma, Kidney Neoplasms, Lung Neoplasms, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Neoplasms, Hereditary Sensory and Autonomic Neuropathies, Pancreatic Neoplasms, Sarcoma, Colorectal Neoplasms, Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡